Literature DB >> 17374134

Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency.

H Okamoto1, C Arii, F Shibata, T Toma, T Wada, M Inoue, Y Tone, Y Kasahara, S Koizumi, Y Kamachi, Y Ishida, J Inagaki, M Kato, T Morio, A Yachie.   

Abstract

Haematopoietic stem cell transplantation (HSCT) is performed for treatment of a broad spectrum of illnesses. Reconstitution of an intact immune system is crucial after transplantation to avoid infectious complications, and above all, the establishment of T cell receptor (TCR) diversity is the most important goal in the procedure. Until recently, little has been known of the mechanism of T cell reconstitution in the very early period after HSCT. In this study, we analysed TCR repertoires sequentially in four patients with severe combined immunodeficiency (SCID) before and after HSCT. In all patients, the TCR repertoires were extremely abnormal before HSCT, whereas after transplantation there was progressive improvement in TCR diversity, based on analysis of the TCR Vbeta repertoire and CDR3 size distributions. Somewhat unexpectedly, there was a significant but transient expansion of TCR diversity 1 month after transplantation in all cases. Clonotypic analysis of TCRs performed in one case showed that many T cell clones shared identical CDR3 sequences at 1 month and that the shared fraction decreased progressively. These results indicate that early expansion of TCR diversity may reflect transient expansion of pre-existing mature T cells from the donor blood, independent of de novo T cell maturation through the thymus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374134      PMCID: PMC1941932          DOI: 10.1111/j.1365-2249.2007.03378.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency.

Authors:  José A Borghans; Robbert G Bredius; Mette D Hazenberg; Helene Roelofs; Els C Jol-van der Zijde; Jeroen Heidt; Sigrid A Otto; Taco W Kuijpers; Willem E Fibbe; Jaak M Vossen; Frank Miedema; Maarten J van Tol
Journal:  Blood       Date:  2006-07-15       Impact factor: 22.113

Review 2.  Exploiting beneficial alloreactive T cells.

Authors:  L D Barber; J A Madrigal
Journal:  Vox Sang       Date:  2006-07       Impact factor: 2.144

3.  High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

Authors:  Katayoun Rezvani; Stephan Mielke; Mojgan Ahmadzadeh; Yasemin Kilical; Bipin N Savani; Josette Zeilah; Keyvan Keyvanfar; Aldemar Montero; Nancy Hensel; Roger Kurlander; A John Barrett
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

Review 4.  CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.

Authors:  Emmanuel Zorn
Journal:  Semin Cancer Biol       Date:  2006-01-23       Impact factor: 15.707

Review 5.  Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment.

Authors:  John Barrett
Journal:  Curr Opin Immunol       Date:  2006-07-26       Impact factor: 7.486

6.  Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.

Authors:  Gustavo Mostoslavsky; Attila J Fabian; Sean Rooney; Frederick W Alt; Richard C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-24       Impact factor: 11.205

7.  Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation.

Authors:  S M Müller; T Kohn; A S Schulz; K M Debatin; W Friedrich
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

Review 8.  Umbilical cord stem cell transplantation for primary immunodeficiencies.

Authors:  M A Slatter; A R Gennery
Journal:  Expert Opin Biol Ther       Date:  2006-06       Impact factor: 4.388

9.  Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.

Authors:  Sharon R Lewin; Glenn Heller; Linqi Zhang; Elaine Rodrigues; Eva Skulsky; Marcel R M van den Brink; Trudy N Small; Nancy A Kernan; Richard J O'Reilly; David D Ho; James W Young
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

10.  Bone marrow transplantation for severe combined immune deficiency.

Authors:  Eyal Grunebaum; Evelina Mazzolari; Fulvio Porta; Daniela Dallera; Adelle Atkinson; Brenda Reid; Luigi D Notarangelo; Chaim M Roifman
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

View more
  2 in total

1.  Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases.

Authors:  M Okajima; T Wada; M Nishida; T Yokoyama; Y Nakayama; Y Hashida; F Shibata; Y Tone; A Ishizaki; M Shimizu; T Saito; K Ohta; T Toma; A Yachie
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

Review 2.  Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantation.

Authors:  Yangqiu Li; Ling Xu
Journal:  Stem Cell Investig       Date:  2015-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.